News & Updates
Filter by Specialty:
Inhaled IFN-β1a shows favourable signals for hospitalized COVID-19 patients
In the phase III SPRINTER trial, inhaled interferon-beta-1a (IFN-β1a) showed encouraging signals for preventing disease progression or death in hospitalized COVID-19 patients.
Inhaled IFN-β1a shows favourable signals for hospitalized COVID-19 patients
22 Sep 2022
Awake prone positioning helps avoid mechanical ventilation in COVID-19
Keeping COVID-19 patients in the prone position even while they are awake appears to reduce the need for invasive mechanical ventilation (IMV), according to a recent Singapore study.
Awake prone positioning helps avoid mechanical ventilation in COVID-19
21 Sep 2022
Trichomoniasis infection ups prostate cancer, benign prostate hyperplasia risk
Men with Trichomoniasis vaginalis infections appear to be at an elevated risk of prostate cancer (PCa) and benign prostate hyperplasia (BPH), according to a recent study.
Trichomoniasis infection ups prostate cancer, benign prostate hyperplasia risk
20 Sep 2022
Female gout patients at higher risk of SARS-CoV-2 infection, severe sequelae
Despite being vaccinated against COVID-19, women with gout have an excess risk of developing SARS-CoV-2 infection as well as severe sequelae from it, according to a study.
Female gout patients at higher risk of SARS-CoV-2 infection, severe sequelae
18 Sep 2022
Vebicorvir plus Nrtl safe, well tolerated in patients with chronic HBV infection
Treatment with vebicorvir (VBR) plus nucleos(t)ide reverse transcriptase inhibitors (NrtIs) among virologically suppressed patients with chronic hepatitis B virus (HBV) is well tolerated and has a favourable safety profile, according to a 24-week study.
Vebicorvir plus Nrtl safe, well tolerated in patients with chronic HBV infection
16 Sep 2022
Smoking during surgical mask use may impair vascular function
Smoking during prolonged use of surgical facemasks due to the COVID-19 pandemic may further compromise vascular function, a study has shown.
Smoking during surgical mask use may impair vascular function
16 Sep 2022
MRNA booster shot durably bolsters defenses against severe COVID-19
Boosting with an mRNA vaccine yields significant protection against severe COVID-19 and may keep people out of the hospital for up to 6 months, as shown in a Singapore study.